Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Leuprorelin, also known as leuprolide, is a manufactured version of a hormone used to treat prostate cancer, breast cancer, endometriosis, uterine fibroids, for early puberty, as part of transgender hormone therapy, or to perform chemical castration of violent sex offenders. It is given by injection into a muscle or under the skin.
The analysis highlights History, Community, Culture and Applications as prominent areas in the source structure around Leuprorelin.
Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.
Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
The extracted context around Leuprorelin shows recurring relationship patterns in the source. For example, Leuprorelin → Abbott Laboratories, Between, Douglas Durand, Durand, False Claims Act, FDA, Gerstein, In October, It, Joseph Gerstein, Justice, Lupron, Medicaid, Medicare, Prescription Drug Marketing Act, Since, TAP, TAP Pharmaceutical Products, The, The FDA Another extracted example is Leuprorelin → A-43818, Abbott Laboratories, Abbott-43818, BANMTooltip British Approved Name, BANTooltip British Approved Name, Bayer AG, DC-2-269, DCFTooltip Dénomination Commune Française, DCITTooltip Denominazione Comune Italiana, Eligard, Fensolvi, INNTooltip International Nonproprietary Name, It, JANTooltip Japanese Accepted Name, Leupromer, Lupron, Name, Previously, TAP Pharmaceuticals, TAP-144. Use these groups to spot repeated connection types before inspecting the individual relationships.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
treatment testosterone use used lupron hormone puberty prostate cancer approved may fda injection effects also side drug gnrh leuprolide agonist
TTTA extracted 135 structured relationships around Leuprorelin. Examples in this analysis include Leuprorelin → 3D model (JSmol) → Interactive image and Leuprorelin → AHFS/Drugs.com → Monograph. The table shows each extracted connection, where it came from and its confidence.
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Leuprorelin | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Leuprorelin | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Leuprorelin | ATC code | L02AE02 (WHO) | 1.00 | infobox |
| Leuprorelin | CAS Number | 53714-56-0 Y 74381-53-6 (acetate) | 1.00 | infobox |
| Leuprorelin | ChEMBL | ChEMBL1201199 N | 1.00 | infobox |
| Leuprorelin | ChemSpider | 571356 N | 1.00 | infobox |
| Leuprorelin | CompTox Dashboard (EPA) | DTXSID50872411 | 1.00 | infobox |
| Leuprorelin | Drug class | GnRH analogue; GnRH agonist; Antigonadotropin | 1.00 | infobox |
| Leuprorelin | DrugBank | DB00007 Y | 1.00 | infobox |
| Leuprorelin | ECHA InfoCard | 100.161.466 | 1.00 | infobox |
| Leuprorelin | Elimination half-life | 3 hours | 1.00 | infobox |
| Leuprorelin | Excretion | Kidney | 1.00 | infobox |
| Leuprorelin | Formula | C59H84N16O12 | 1.00 | infobox |
| Leuprorelin | IUPHAR/BPS | 1175 | 1.00 | infobox |
| Leuprorelin | KEGG | D08113 Y | 1.00 | infobox |
| Leuprorelin | Legal status | AU: S4 (Prescription only) | 1.00 | infobox |
| Leuprorelin | Legal status | CA: ℞-only | 1.00 | infobox |
| Leuprorelin | Legal status | US: ℞-only | 1.00 | infobox |
| Leuprorelin | Legal status | EU: Rx-only | 1.00 | infobox |
| Leuprorelin | Legal status | In general: ℞ (Prescription only) | 1.00 | infobox |
| Leuprorelin | License data | US DailyMed: Leuprolide | 1.00 | infobox |
| Leuprorelin | MedlinePlus | a685040 | 1.00 | infobox |
| Leuprorelin | Molar mass | 1209.421 g·mol−1 | 1.00 | infobox |
| Leuprorelin | Other names | leuprolide, leuprolidine, A-43818, Abbott-43818, DC-2-269, TAP-144 | 1.00 | infobox |
| Leuprorelin | Pregnancy category | AU: D | 1.00 | infobox |
| Leuprorelin | PubChem CID | 657181 | 1.00 | infobox |
| Leuprorelin | Routes of administration | implant, subcutaneous, intramuscular | 1.00 | infobox |
| Leuprorelin | Trade names | Lupron, Eligard, Lucrin, Lupaneta, others | 1.00 | infobox |
| Leuprorelin | UNII | EFY6W0M8TG | 1.00 | infobox |
The concept neighborhoods around Leuprorelin bring nearby vocabulary together. In this analysis, examples include Use, Treatment and Medical. Use the clusters to find adjacent concepts and terminology that may deserve separate research.
For Leuprorelin, one of the stronger structural bridges in this analysis connects Leuprorelin with Overview. Bridges highlight paths between different parts of the map and can reveal research angles that are easy to miss in a flat list.
TTTA analyzes the structure around Leuprorelin to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as History, Community, Culture & Applications, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.
Source: Wikipedia — Leuprorelin · EN edition · Analysis: TopicsToTalkAbout